STOCK COMPENSATION PLANS (Tables)

3 Months Ended

Feb. 28, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the status of stock options granted by MultiCell at February 28, 2014, and changes during the three months then ended is presented in the following table:

				Weighted
		Weighted		Average
	Shares	Average		Remaining	Aggregate
	Under	Exercise		Contractual	Intrinsic
	Option	Price		Life	Value
Outstanding at November 30, 2013	50,399,503	$	0.0040	3.7 years	$	-
Granted	25,074,710		0.0008
Exercised	-		-
Expired or forfeited	-		-
Outstanding at February 28, 2014	75,474,213	$	0.0029	3.9 years	$	-
Exercisable at February 28, 2014	32,783,523	$	0.0055	2.9 years	$	-

Xenogenics Corporation [Member]

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the status of Xenogenics’ stock options at at February 28, 2014, and changes during the three months then ended is presented in the following table:

				Weighted
		Weighted		Average
	Shares	Average		Remaining
	Under	Exercise		Contractual
	Option	Price		Life
Outstanding at November 30, 2013	4,250,000	$	0.2460	2.3 years
Granted	-		-
Exercised	-		-
Expired or forfeited	-		-
Outstanding at February 28, 2014	4,250,000	$	0.2460	2.1 years
Exercisable at February 28, 2014	2,000,000	$	0.2460	2.2 years